In addition and most importantly, Lanni et al. [14] were able to develop a rapid, easy and quantitative flow cytometric approach for the discrimination of conformational mutant p53-bearing cells from AD patients compared to non-AD controls, using small volumes of blood. The gene discussed is TP53; the disease is Alzheimer disease.